CBD products will soon be on the shelves of two mainstream US drugstore chains. CVS – one of the largest retail pharmacy chains in the US – is already selling a range of products in at least eight US states and Walgreens intends to sell products in nine states.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Medical and recreational cannabis – a global overview
Check out our new regulatory data on medical and recreational cannabis in 54 jurisdictions around the world
The report, accompanied by a more detailed database, provides an overview of the regulatory situation in the selected countries, using maps, and assesses the likelihood that the status quo may change in the future.